These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8442917)

  • 1. In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection.
    Scott ME; Landay AL; Lint TF; Spear GT
    AIDS; 1993 Jan; 7(1):37-41. PubMed ID: 8442917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
    June RA; Landay AL; Stefanik K; Lint TF; Spear GT
    Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in antigen expression on B lymphocytes during HIV infection.
    Ginaldi L; De Martinis M; D'Ostilio A; Marini L; Quaglino D
    Pathobiology; 1998; 66(1):17-23. PubMed ID: 9577962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers.
    Benedetto A; Di Caro A; Camporiondo MP; Gallone D; Zaniratti S; Tozzi V; Elia G
    Clin Immunol Immunopathol; 1992 Feb; 62(2):139-47. PubMed ID: 1370396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the C3d/EBV receptor and of other cell membrane surface markers is altered upon HIV-1 infection of myeloid, T, and B cells.
    Larcher C; Schulz TF; Hofbauer J; Hengster P; Romani N; Wachter H; Dierich MP
    J Acquir Immune Defic Syndr (1988); 1990; 3(2):103-8. PubMed ID: 2136911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection.
    Munson LG; Scott ME; Landay AL; Spear GT
    Clin Immunol Immunopathol; 1995 Apr; 75(1):20-5. PubMed ID: 7533682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C3d,g/Epstein-Barr virus receptor density on human B-lymphocytes estimated by immunoenzymatic assay and immunocytochemistry.
    Rask R; Rasmussen JM; Hansen HV; Bysted P; Svehag SE
    J Clin Lab Immunol; 1988 Mar; 25(3):153-6. PubMed ID: 2969415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE).
    Levy E; Ambrus J; Kahl L; Molina H; Tung K; Holers VM
    Clin Exp Immunol; 1992 Nov; 90(2):235-44. PubMed ID: 1424280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways.
    Bouillie S; Barel M; Drane P; Cassinat B; Balbo M; Holers VM; Frade R
    Eur J Immunol; 1995 Sep; 25(9):2661-7. PubMed ID: 7589142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell activation induced by cross-linking CD3 and CD28 leads to silencing of Epstein-Barr virus/C3d receptor (CR2/CD21) gene and protein expression.
    Masilamani M; von Seydlitz E; Bastmeyer M; Illges H
    Immunobiology; 2002 Dec; 206(5):528-36. PubMed ID: 12607728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.
    Döpper S; Wilflingseder D; Prodinger WM; Stiegler G; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2003 Aug; 33(8):2098-107. PubMed ID: 12884283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum regulates the expression of complement receptor 2 on human B cell lines.
    Tolnay M; Tsokos GC
    Immunopharmacol Immunotoxicol; 2000 May; 22(2):205-19. PubMed ID: 10952027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.
    Tóth FD; Szabó B; Ujhelyi E; Pálóczi K; Horváth A; Füst G; Kiss J; Bánhegyi D; Hollán SR
    AIDS; 1991 Mar; 5(3):263-8. PubMed ID: 1676275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells.
    Bánki Z; Wilflingseder D; Ammann CG; Pruenster M; Müllauer B; Holländer K; Meyer M; Sprinzl GM; van Lunzen J; Stellbrink HJ; Dierich MP; Stoiber H
    J Immunol; 2006 Sep; 177(5):3469-76. PubMed ID: 16920989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L; Chen K; Huber BT; Holers VM
    Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of complement receptors 1 and 2 on mouse splenic B cells using flow cytometry.
    Donius LR; Weis JH
    Methods Mol Biol; 2014; 1100():305-10. PubMed ID: 24218269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.
    Klein SA; Dobmeyer JM; Dobmeyer TS; Pape M; Ottmann OG; Helm EB; Hoelzer D; Rossol R
    AIDS; 1997 Jul; 11(9):1111-8. PubMed ID: 9233457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mitogen activated protein kinases via complement receptor type 2.
    Luo MH; Chen ML; Stoiber H; Dierich MP
    Chin Med J (Engl); 2004 Dec; 117(12):1802-8. PubMed ID: 15603708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.